Biovie Correlations
BIVI Stock | USD 3.05 0.06 1.93% |
The current 90-days correlation between Biovie Inc and Hookipa Pharma is 0.08 (i.e., Significant diversification). The correlation of Biovie is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Biovie |
Moving together with Biovie Stock
Moving against Biovie Stock
0.72 | A | Agilent Technologies Earnings Call This Week | PairCorr |
0.44 | PFE | Pfizer Inc Aggressive Push | PairCorr |
0.44 | TCHH | Trustcash Holdings | PairCorr |
0.42 | ME | 23Andme Holding | PairCorr |
0.32 | AGL | agilon health | PairCorr |
0.31 | KZR | Kezar Life Sciences | PairCorr |
0.77 | DD | Dupont De Nemours Fiscal Year End 4th of February 2025 | PairCorr |
0.61 | MCD | McDonalds Fiscal Year End 3rd of February 2025 | PairCorr |
0.6 | IBM | International Business Fiscal Year End 22nd of January 2025 | PairCorr |
0.58 | GE | GE Aerospace Fiscal Year End 28th of January 2025 | PairCorr |
0.48 | HYMTF | Hyundai Motor | PairCorr |
0.43 | KO | Coca Cola Aggressive Push | PairCorr |
0.43 | HD | Home Depot | PairCorr |
0.4 | CAT | Caterpillar Fiscal Year End 3rd of February 2025 | PairCorr |
0.33 | TLK | Telkom Indonesia Tbk | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Biovie Stock performing well and Biovie Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Biovie's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
INZY | 2.74 | (1.09) | 0.00 | (0.42) | 0.00 | 5.68 | 16.62 | |||
DAWN | 2.10 | (0.08) | (0.03) | 0.03 | 2.72 | 3.84 | 11.44 | |||
TERN | 3.37 | (0.50) | 0.00 | (0.29) | 0.00 | 5.68 | 34.09 | |||
ELDN | 3.42 | 0.57 | 0.13 | (22.59) | 3.04 | 10.09 | 28.12 | |||
HOOK | 2.80 | (1.37) | 0.00 | (1.17) | 0.00 | 4.05 | 22.98 | |||
XFOR | 4.97 | (0.84) | 0.00 | (0.45) | 0.00 | 6.90 | 62.35 | |||
ABOS | 3.55 | (0.52) | 0.00 | (0.05) | 0.00 | 7.52 | 28.07 | |||
MREO | 2.65 | (0.43) | 0.00 | (0.15) | 0.00 | 5.14 | 19.32 | |||
AMLX | 4.24 | 1.32 | 0.27 | 1.26 | 4.02 | 10.06 | 33.56 |
Biovie Corporate Management
Joseph MD | Executive Officer | Profile | |
Clarence Ahlem | Senior Operations | Profile | |
Joanne CPA | Treasurer CFO | Profile | |
Denise Smith | Senior Development | Profile | |
Sarah Hoit | Chief Officer | Profile | |
MBA MBA | CEO Pres | Profile |